BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, gives notice that the Group will be announcing its results for the year ended 31 December 2021 on Monday 28 February 2022.
The Group is delighted to announce that it expects to report full year revenue and EBITDA for 2021 slightly ahead of market expectations (which were raised during the year on 23 August 2021) reflecting strong growth from ongoing operations* with increased revenue in both divisions. In particular, this has been driven by significant growth in the Group’s Diagnostics unit of the Bio-Medical division.
Looking ahead, the Group entered the new year with a substantially higher backlog from ongoing operations than at the same point of the prior year and the strong momentum of 2021 has continued. Accordingly, the Group remains on track to deliver significant growth for full year 2022 in line with market expectations.
Further detail will be provided in the Group’s full year results announcement on 28 February 2022.
Presentations to analysts and investors
Dr Zvi Marom, Chief Executive Officer, and Moti Nagar, Chief Financial Officer, will be holding presentations in London on the day of the results for:
· analysts at 9.00am GMT; and for
· private shareholders at 5.30pm GMT.
To register to attend either presentation, please contact laraapstein@luther.co.uk .
* Excluding the contribution to 2021 and 2020 from NGSoft, a non-core subsidiary that the Group sold in March 2021, and the contribution to 2020 from a significant contract to supply critical care ventilators, which was exceptional in nature.
Enquiries:
|
BATM Advanced Communications |
|
|
Dr Zvi Marom, Chief Executive Officer |
+972 9866 2525 |
|
Moti Nagar, Chief Financial Officer |
|
|
Shore Capital |
|
|
Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)
|
+44 20 7408 4050 |
|
Luther Pendragon |
|
|
Harry Chathli, Claire Norbury |
+44 20 7618 9100 |